Betoptic S

See also: Generic Betoptic

Betoptic S is a brand name of betaxolol ophthalmic, approved by the FDA in the following formulation(s):

BETOPTIC S (betaxolol hydrochloride - suspension/drops; ophthalmic)

• 
  Manufacturer: ALCON
  
  Approval date: December 29, 1989
  
  Strength(s): EQ 0.25% BASE ^[RLD]

Has a generic version of Betoptic S been approved?

No. There is currently no therapeutically equivalent version of Betoptic S available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Betoptic S. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Betoptic S.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 8, 2010 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Betoptic-S Drops Consumer Information (Wolters Kluwer)
• Betoptic S Consumer Information (Cerner Multum)
• Betoptic S Advanced Consumer Information (Micromedex)
• Betoptic S eent AHFS DI Monographs (ASHP)
• Betaxolol Drops Consumer Information (Wolters Kluwer)
• Betaxolol ophthalmic Consumer Information (Cerner Multum)
• Betaxolol Ophthalmic Advanced Consumer Information (Micromedex)
• Betaxolol Hydrochloride eent AHFS DI Monographs (ASHP)